Letters to the Editor

Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
BMT and cell therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
Haematologica Early view Aug 14, 2025 https://doi.org/10.3324/haematol.2025.288174